Survivorship Care is highlighted, providing emotional, physical, and practical care for patients, along with other positive data to be aware of.

Elahere showed superior efficacy over chemotherapy in progression-free survival, objective response rate, and overall survival in the MIRASOL trial. The treatment reduced the risk of tumor progression ...

How do the primary analysis results of the MIRASOL trial differ from the primary analysis results? Were there any unexpected findings? Back then, when we did the primary analysis, we had a follow ...

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...

AbbVie (ABBV) announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE in women with folate receptor alpha-positive platinum-resistant ...

Full FDA approval was granted based on the phase 3 MIRASOL trial results, reinforcing its clinical benefits. Experts recommend mirvetuximab soravtansine as the standard of care, highlighting the ...

US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its antibody-drug conjugate (ADC) Elahere against chemotherapy for treating ...

Phase III IMvoke010 trial found that maintenance treatment with Tecentriq (atezolizumab) did not significantly improve ...

Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant ...